Here’s a detailed summary of “Entering Our Fourth Decade: The Next Chapter of Liver Transplantation” by Andrés Cárdenas and Timuçin Taner, dated October 28, 2025.
Overview
This editorial marks the beginning of the authors’ tenure as Editors-in-Chief of Liver Transplantation and sets out their vision for the journal’s fourth decade. They reflect on the publication’s history, current standing, and the future directions they intend to pursue.
Historical Context
- The journal was founded in 1995 as Liver Transplantation and Surgery, jointly managed by the AASLD (American Association for the Study of Liver Diseases) and the ILTS (International Liver Transplantation Society).
- This partnership recognized that progress in liver transplantation depends on close collaboration among hepatology, surgery, immunology, and multidisciplinary care.
- After a period of separation, AASLD and ILTS have reunited, reaffirming the journal as the central scholarly home for the field.
- The new leadership model mirrors clinical practice — one hepatologist and one surgeon sharing editorial responsibility.
Vision for the Next Decade
The editors describe a dual mission:
- Preserve the journal’s legacy of excellence in publishing rigorous science and innovative techniques.
- Expand its scope and impact by integrating cutting-edge developments across related disciplines.
They aim to:
- Broaden the scientific base, increasing representation of basic and translational research in immunology, genomics, regenerative medicine, and organ preservation.
- Maintain strong representation of pre-transplant management, surgical innovation, clinical outcomes, and policy.
- Expand coverage across the full continuum of liver disease, from portal hypertension and cirrhosis to survivorship after transplantation.
Editorial Strategy
- The editors have formed an international and diverse editorial board representing five continents, acknowledging that liver transplantation is a global enterprise—from major academic centers to resource-limited hospitals.
- Their goal is for Liver Transplantation to reflect global practice and remain relevant to an international readership.
Challenges and Opportunities
The editorial highlights several critical challenges:
- Organ scarcity
- Disparities in access to transplantation
- Long-term complications of immunosuppression
- Rising burden of liver disease worldwide
At the same time, they identify emerging opportunities:
- Xenotransplantation
- Cell-based and regenerative therapies
- Machine perfusion technologies
- Biomarkers of immune tolerance
- Innovations in interventional radiology, endoscopy, and surgical techniques
The editors see the journal as a catalyst for scientific progress and informed discourse, helping the field navigate these transformative changes.
Commitment and Call to Action
They emphasize the importance of rigorous science and public trust, especially amid societal trends that promote misinformation and skepticism toward science.
Their editorial philosophy is guided by fairness, rigor, vision, and a focus on improving patient lives.
They close with an invitation for researchers, clinicians, and scientists to contribute, reaffirming that the strength of the field lies in its collaborative community and shared purpose.
Key Message
As Liver Transplantation enters its fourth decade, the journal seeks to unite the global liver-transplant community, uphold scientific integrity, and broaden its role as the premier forum for discovery, debate, and patient-centered innovation in liver disease and transplantation.